Low molecular weight heparin and atherosclerosis

被引：0
|
作者：
Hunt D. [1 ]
机构：
[1] Section of General Internal Medicine, Ben Taub General Hospital, Houston, TX 77030
来源：
Current Atherosclerosis Reports | 2004年 / 6卷 / 2期
关键词：
Percutaneous Coronary Intervention; Acute Coronary Syndrome; Enoxaparin; Abciximab; Unfractionated Heparin;
D O I：
10.1007/s11883-004-0103-9
中图分类号：
学科分类号：
摘要：
Low molecular weight heparin (LMWH) has dramatically impacted the treatment of venous thromboembolic disease and acute coronary syndromes. Recent studies help define the role of these agents for patients undergoing percutaneous coronary interventions and for patients treated with thrombolytic agents for ST-segment elevation myocardial infarction. Recent studies also suggest potential usefulness of LMWH for patients with peripheral vascular disease and its limits of utility in stroke. This review summarizes the evidence about the use of LMWH in these clinical situations. Copyright © 2004 by Current Science Inc.
引用
收藏
页码：140 / 147
页数：7
相关论文
共 50 条
  • [41] Interaction of low molecular weight heparin with ketorolac
    Green, D
    Klement, P
    Liao, P
    Weitz, J
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 127 (06): : 583 - 587
  • [42] Low molecular weight heparin for lichen planus
    Graham-Brown, RAC
    BRITISH JOURNAL OF DERMATOLOGY, 1999, 141 (06) : 1002 - 1003
  • [43] LOW-MOLECULAR-WEIGHT HEPARIN IN HEMODIALYSIS
    DEUBER, HJ
    SCHULZ, W
    KLINISCHE WOCHENSCHRIFT, 1987, 65 (20): : 992 - 992
  • [44] Uses of low-molecular-weight heparin
    Bounameaux, H
    Goldhaber, SZ
    BLOOD REVIEWS, 1995, 9 (04) : 213 - 219
  • [45] A study of low molecular weight heparin prescription
    Callaert, S
    Chouaid, C
    Causse, R
    Thebault, A
    THERAPIE, 1998, 53 (06): : 587 - 590
  • [46] Antiproliferative effects of low molecular weight heparin
    Fletcher, JP
    Ao, PY
    Hawthorne, WJ
    ANZ JOURNAL OF SURGERY, 2004, 74 (09) : 793 - 796
  • [47] ERYTHROMELALGIA AND LOW-MOLECULAR-WEIGHT HEPARIN
    CONRI, CL
    AZOULAI, P
    CONSTANS, J
    SEBBAN, A
    LEMOUROUX, A
    MIDY, D
    BASTE, JC
    THERAPIE, 1994, 49 (06): : 518 - 519
  • [48] LOW-MOLECULAR-WEIGHT HEPARIN - REPLY
    HULL, RD
    RASKOB, GE
    PINEO, GF
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (11): : 818 - 818
  • [49] Safety of low molecular weight heparin in pregnancy
    Matysková, M
    Buliková, A
    Slechtová, M
    Meluzinová, H
    Smejkal, P
    THROMBOSIS AND HAEMOSTASIS, 1999, : 681 - 682
  • [50] WHY LOW-MOLECULAR-WEIGHT HEPARIN
    MAMMEN, EF
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1990, 16 : 1 - 4
12345